Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "lymphocyte count"

Prognostic Significance of Combination of Preoperative Platele...

by Hua Zhang, Lianmin Zhang, Kaikai Zhu, Bowen Shi, Yuesong Yin, Jinfang Zhu, Dongsheng Yue, Bin Zhang, Changli Wang Introduction The aim of this study was to investigate the prognostic significance of the combination of the preoperative platelet ... Plosone.org, 3 weeks ago

1 images for "lymphocyte count"

MDLinx, 1 week ago

Researchers from Wonkwang University Describe Findings in Gastric Cancer (Absolute monocyte and lymphocyte count prognostic score for patients with...

Researchers from Wonkwang University Describe Findings in Gastric Cancer (Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer) By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on ...
 4 Traders1 month ago

Acute Transient Global Ventricular Dysfunction As the Presenting Symptom of Anaplastic Large-Cell Lymphoma [DIAGNOSIS IN ONCOLOGY]

A 36-year-old man presented to the hospital with a 4-day history of fever, sore throat, perspiration, dyspnea, and generalized myalgia. He had no relevant past medical problems, nor history of illicit drug use. On arrival, he was hemodynamically ...
 Journal of Clinical Oncology1 week ago

Novartis announces Phase III study of Arzerra® met primary endpoint of improved progression-free survival in patients with relapsed CLL

Positive top-line results seen with Arzerra plus fludarabine and cyclophosphamide in chronic lymphocytic leukemia (CLL) patients when initial treatment stopped working CLL is the most commonly diagnosed adult leukemia in Western countries, ...
 Biotechgate1 month ago Genmab Announces Phase III Study of Arzerra(r) Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL  Yahoo! Finance1 month ago Genmab A/S : Announces Phase III Study of Arzerra® Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL  4 Traders1 month ago Novartis : announces Phase III study of Arzerra® met primary endpoint of improved progression-free survival in patients with relapsed CLL»  4 Traders1 month ago
[x]  
Metro Weekly

Health trial shows benefit to early start for HIV treatments

Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. (Image courtesy of the Centers for Disease Control and Prevention's Public Health Image Library. Photo Credit: C. Goldsmith, Content Providers: CDC/ C. Goldsmith, P.
 Metro Weekly1 day ago

CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis

Abstract CD47 is a widely expressed receptor that regulates immunity by engaging its counter-receptor SIRPα on phagocytes and its secreted ligand thrombospondin-1. Mice lacking CD47 can exhibit enhanced or impaired host responses to bacterial ...
 Plosone.org3 days ago

TLC cancels the Duggars Philadelphia appearance

Television host/producer Marc Summers has plenty to be thankful for. Diagnosed with lymphocytic leukemia in 2010, Summers did two years of chemo, is in remission and "feels like a million bucks." That's good because he's crazy busy executive ...
 Metro.us3 days ago

Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm

Abstract This randomized, double-blind, placebo-controlled, 6-arm, parallel-design study investigated cardiac and hematological pharmacodynamic effects of ceralifimod (ONO-4641), a selective sphingosine-1-phosphate (S1P) receptor modulator, over a ...
 Journal of Clinical Pharmacology4 days ago

New ibrutinib (IMBRUVICA®) Data to be Showcased at American Society of Clinical Oncology (ASCO) Annual Meeting

IMBRUVICA Combination Data in Chronic Lymphocytic Leukemia to be Featured in Official ASCO Press Program SUNNYVALE, Calif., May 13, 2015 /PRNewswire/ — Pharmacyclics, Inc. (NASDAQ: PCYC) announced today that ibrutinib (IMBRUVICA(®)) ...
 Red Orbit2 weeks ago European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA® (ibrutinib) to Treat..  ADVFN India1 week ago Pharmacyclics Release: European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA (ibrutinib) To Treat Waldenstrom's Macroglobulinemia  BioSpace1 week ago Pharmacyclics (PCYC) Release: European Medicines Agency Issues Positive Opinion, Recommends Full Approval of IMBRUVICA (ibrutinib) To Treat Waldenstrom's Macroglobulinemia 5/22/2015  ClinicSpace1 week ago
[x]  

Contributions of T Lymphocyte Abnormalities to Therapeutic Outcomes in Newly Diagnosed Patients with Immune Thrombocytopenia

T cell abnormalities have been reported to play an important role in pathogenesis of immune thrombocytopenia (ITP) besides specific autoantibodies towards platelet. The aim of this study was to explore the clinical importance of T lymphocyte subsets ...
 Bionity.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less